Piśmiennictwo:

 1. Hudaib M., Aldahasi W.B., Khdair A., Salah R., Alkhatib H.S., Bustanji Y., Mohammad M.K.,  A simple and rapid HPLC-UV method for the determination of umckalin, as an herbal marker, in the cough syrup of pelargonium extract, Jordan J. Pharm. Sci., 2010, 3, 109.
2. Brendler T., van Wyk B.E., A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae), J. Ethnopharm., 2008, 119, 420.
3. Bowles E.J., Cheras P., Stevens J., Myers S.A., A survey of aromatherapy practices in aged care facilities in northern NSW, Australia, Int. J. Aromather., 2005, 15, 42.
4. Farmakopea Polska VIII, Tom 3., 2621.
5. Latté K.P., Kayser O., Tan N., Kaloga M., Kolodziej H., Unusual coumarin patterns of Pelargonium species forming the origin of the traditional herbal medicine umckaloabo, Zeitschrift fur Naturforschung - Section C, J. Biosci., 2000, 55, 528.
6. Saraswathi J., Venkatesh K., Nirmala B., Majid Hameed H., Roja Rani A., Phytopharmacological importance of Pelargonium Species, J. Med. Plants Res., 2011, 13, 2587.
7. Kayser O., Kolodziej H., Highly oxygenated coumarins form Pelargonium sidoides, Phytochem., 1995, 39, 1181.
8. Kolodziej H., Traditionally used Pelargonium species: chemistry and biological activity of umckaloabo extracts and their constituents, Curr. Topic. Phytochem., 2000, 3, 77.
9. Kolodziej H., Pelargonium reniforme and Pelargonium sidoides – their botany, chemistry and medicinal use, Geranium and Pelargonium, Taylor & Francis, London, 2002, 262.
 0. Franco L., de Oliveira B.H., Determination of umckalin in commercial tincture and phytopreparations containing Pelargonium sidoides by HPLC: Comparison of sample preparation procedure, Talanta, 2010, 81, 1368.
 1. Kolodziej H., Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo®, Phytomed., 2007, 14, 9.
 2. White A.G., Davies-Coleman M.T., Ripley B.S., Measuring and optimising concentration in wild-harvest and cultivated Pelargonium sidoides (Geraniaceae), South Afr J Bot, 2008, 74, 260.
 3. Bladt S, Wagner H., Cumarindrogen: Qualitatsprüfung der Umcka-Droge und ihrer Zubereitungen, Deutsher Apotheker Zeutung, 1988, 128, 292.
 4. Schötz K, Nödler M., Mass spectroscopic characterization of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs® 7630) and pharmacological screening in CNS models, Phytomed., 2007, 14, 32.
 5. Gödecke T., Kaloga M., Kolodziej H., A phenol glucoside, uncommon coumarins and flavonoids from Pelargonium sidoides DC., Z. Naturforsch. B., 2005, 60, 677.
 6. Kayser O., Kolodziej H., Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme, Planta Medica, 1997, 63, 508.
 7. Lewu F.B., Grierson D.S., Afolayan A.J., Extracts from Pelargonium sidoides inhibit the growth of bacteria and fungi, Pharm. Biol., 2006, 44, 279.
 8. Golovatiuk A., Tschtschalin A.G.,  Wirksamkeit einen Ekstrakten aus Pelargonium sidoides (EPS 7630) versus Placebo bei aktuer Bronchitis. Forschung und klinische Anwendung., Steinkopff-Verlag, Darmstadt,  2002, 3, 12.
 9. Bachert C., Schapoval A., Funk P., Kieser M., Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial., J. App. Microbiol., 2009,  106, 1184.
20. Bell W., Kilian P.,  EPs® 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells, Phytomed., 2007, 14, 5.
2 .  Kolodziej H., Kayser O., Radtke O.A., Kiderlen A.F., Koch E., Pharmacological profile of extracts of Pelargonium sidoides and their constituents, Phytomed., 2003, 10, 18.
22. Mativandlela S.P.N., Meyer J.J.M., Hussein A.A., Lall N., Antitubercular activity of compounds isolated from Pelargonium sidoides, Pharm. Biol., 2007, 45, 645.
23. Taylor P.W., Antimycobacterial activity of indigenous South African plants, South Afr. Med. J., 2003, 93, 904.
24. Schnitzler P., Schneider S., Stintzing F.C., Carle R., Reichling J., Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus,  Phytomed., 2008, 15, 1108.
25. Thäle C., Kiderlen A., Kolodziej H., Anti-infective mode of action of EPs® 7630 at the molecular level, Planta Medica, 2008, 74, 675.
26. Kolodziej H., Antimicrobial, antiviral and immunomodulatory activity studies of Pelargonium sidoides (EPs® 7630) in the context of health promotion, Pharmaceut., 2011, 10, 1295.
27. Trun W., Kiderlen A.F., Kolodziej H., Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (Eps® 7630), Phytomed., 2006, 13, 570.
28. Kolodziej H., Kiderlen A.F., In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630, Phytomed., 2007, 14, 18.
29. Krone D., Mannel M., Pauli E., Hummel T., Immunomodulatory principles of Pelargonium sidoides,  Phytother. Res., 2001, 15, 122.
30. Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs® 7630) in adults with acute bronchitis. Phytomedicine 2003, 10:7-17.
31. Matthys H, Heger M. EPs® 7630 solution – an effective therapeutic option in acute and exacerbating bronchitis. Phytomedicine 2007b, 14:65-68.
32. Chuchalin A.G., Berman B., Lehmacher W., Treatment of acute bronchitis in adults with Pelargonium sidoides preparation (EPs® 7630): a randomized, double-blind, placebo-controlled trial, Expl., 2005, 1, 437.
33. Matthys H., Funk P., EPs® 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomized, double-blind, placebo-controlled, multicentre trial, Planta Med. 2008, 74, 686.
34. Matthys H., Heger M., Treatment of acute bronchitis in adults with a liquid herbal drug preparation from Pelargonium sidoides (EPs® 7630): a randomized, double-blind, placebo-controlled, multicentre study, Curr. Med. Res. Opin., 2007a, 23, 323.
35. Schulz V., Dosisfindinungstudie zur Wirksamkeit von Pelargonium sidoides extrakt (EPs® 7630 in neuer Tablettenform) bei 405 Erwachsenen mit acuter Bronchitis, Z. Phytother., 2008, 29, 37.
36. Agbabiaka T.B., Guo R., Ernst E., Pelargonium sidoides for acute bronchitis: A systemic review and meta-analysis, Phytomed., 2008, 15, 378.
37. Haidvogl M., Heger M., Treatment effect and safety of EPs® 7630-solution in acute bronchitis in childhood: Report of a multicentre observational study, Phytomed., 2007, 14, 60.
38. Schapowal A., Heger M., EPs® 7630 Lösung (Umckaloabo®) bei Sinusitis, Z. Phytother., 2007, 28, 58.  
39. Bachert C., Schapowal A., Funk P., Kieser M., Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs® 7630: a randomized, double-blind, placebo-controlled trial, Rhinology, 2009, 47, 51.
40. Lizogub V.G., Riley D.S., Heger M., Efficacy of Pelargonium sidoides preparation in patients with the common cold: a randomized, double-blind, placebo-controlled clinical trial, Explore 2007, 3,573.
41. Bereznoy V.V., Riley D.S., Wassmer G., Heger M., Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-haemolytic streptococcus tonsillophyaryngitis: a randomized, double-blind, placebo-controlled trial, Altern. Ther. Health Med., 2003, 9, 68.
42. Loew D., Hauer H., Koch E., Differentiated risk consideration: Coumarins in phytopharmaceuticals, Pharmazeutische Zeitung, 2009, 154.
43. Koch E., Biber A., Treatment of rats with the Pelargonium sidoides extract EPs® 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin, Phytomed., 2007, 14, 40.
44. Rosato A., Vitali C., Piarulli M., Mazzotta M., Argentieri M.P., Mallamaci R., In vitro synergic efficacy of the combination of nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species, Phytomed., 2009, 16, 972.
45. Malik T., Singh P., Pant S., Chauhan N., Lohani H., Potentiation of antimicrobial activity of ciprofloxacin by Pelargonium graveolens essential oil against selected uropathogens, Phytother. Res., 2011, 25, 1225.